Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors

被引：0
|
作者：
Rodman, Samuel [1 ]
Cagle, Brianna [1 ]
Liu, Dijie [2 ]
Schultz, Michael [3 ]
Li, Mengshi [2 ]
机构：
[1] Viewpoint Mol Targeting Inc, Coralville, IA USA
[2] Perspect Therapeut Inc, Seattle, WA USA
[3] Univ Iowa, Iowa City, IA 52242 USA
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2023年 / 126卷
关键词：
FDA APPROVAL; METASTATIC MELANOMA; NIVOLUMAB;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-285
引用
收藏
页码：S261 / S262
页数：2
相关论文
共 50 条
  • [31] Low-dose HDACi potentiates anti-tumor activity of macrophages in immunotherapy
    Li, Xiaolei
    Dai, Hanren
    Wang, Hua
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [32] Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Nishida Masatoshi
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (06) : 777 - 779
  • [33] Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?
    Maximilian Haist
    Henner Stege
    Michael Kuske
    Julia Bauer
    Annika Klumpp
    Stephan Grabbe
    Matthias Bros
    Cancer and Metastasis Reviews, 2023, 42 : 481 - 505
  • [34] Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?
    Haist, Maximilian
    Stege, Henner
    Kuske, Michael
    Bauer, Julia
    Klumpp, Annika
    Grabbe, Stephan
    Bros, Matthias
    CANCER AND METASTASIS REVIEWS, 2023, 42 (02) : 481 - 505
  • [35] Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease
    Avogadri, Francesca
    Mittal, Deepak
    Saccheri, Fabiana
    Sarrafiore, Massimo
    Ciocca, Mario
    Larghi, Paola
    Orecchia, Roberto
    Rescigno, Maria
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (07) : 1937 - 1947
  • [36] Pulsed electric field ablation as a candidate to enhance the anti-tumor immune response to immune checkpoint inhibitors
    Arciga, Blake M.
    Walters, Dustin M.
    Kimchi, Eric T.
    Staveley-O'Carroll, Kevin F.
    Li, Guangfu
    Teixeiro, Emma
    Rachagani, Satyanarayana
    Kaifi, Jussuf T.
    CANCER LETTERS, 2025, 609
  • [37] Cost effectiveness of immune checkpoint inhibitors in combination with targeted therapies in metastatic renal cell carcinoma
    Mason, N.
    Kim, Y.
    Shah, S.
    Adashek, J. J.
    Manley, B. J.
    Spiess, P. E.
    Chahoud, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S692 - S692
  • [38] Tumor antigen vaccine enhances anti-tumor effects of immune checkpoint inhibitors against refractory cancers
    Ueda, S.
    Ushijima, M.
    Irie, A.
    Senju, S.
    Ito, K.
    Hamana, H.
    Kishi, H.
    Ogasawara, K.
    Udaka, K.
    Nishimura, Y.
    Eto, M.
    EUROPEAN UROLOGY, 2023, 83
  • [39] The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules
    Keisari, Yona
    Kelson, Itzhak
    CELLS, 2021, 10 (02) : 1 - 13
  • [40] TUMOR ANTIGEN VACCINE ENHANCES ANTI-TUMOR EFFECTS OF IMMUNE CHECKPOINT INHIBITORS AGAINST REFRACTORY CANCERS
    Ueda, Shohei
    Ushjima, Miho
    Irie, Atsushi
    Nishimura, Yasuharu
    Eto, Masatoshi
    JOURNAL OF UROLOGY, 2022, 207 (05): : E199 - E200
12345